Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation

被引:79
|
作者
Gonzales, MJ
Delwart, E
Rhee, SY
Tsui, R
Zolopa, AR
Taylor, J
Shafer, RW
机构
[1] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Stat, Stanford, CA 94305 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
来源
JOURNAL OF INFECTIOUS DISEASES | 2003年 / 188卷 / 03期
关键词
D O I
10.1086/376534
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined consecutive protease (PR) and reverse transcriptase (RT) sequences from human immunodeficiency virus (HIV) type 1-infected individuals, to distinguish changes resulting from sequence evolution due to possible superinfection. Between July 1997 and December 2001, greater than or equal to2 PR and RT samples from 718 persons were sequenced at Stanford University Hospital. Thirty-seven persons had highly divergent sequence pairs characterized by a nucleotide distance of >4.5% in PR or >3.0% in RT. In 16 of 37 sequence pairs, divergence resulted from the loss of mutations during a treatment interruption or from the gain of mutations with reinstitution of treatment. tat and/or gag sequencing of HIV-1 from cryopreserved plasma samples could be performed on 15 of the 21 divergent isolate pairs from persons without a treatment interruption. The sequences of these genes, unaffected by selective drug pressure, were monophyletic. Although HIV-1 PR and RT genes from treated persons may become highly divergent, these changes usually are the result of sequence evolution, rather than superinfection.
引用
收藏
页码:397 / 405
页数:9
相关论文
共 50 条
  • [1] Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure
    Tsui, R
    Herring, BL
    Barbour, JD
    Grant, RM
    Bacchetti, P
    Kral, A
    Edlin, BR
    Delwart, EL
    JOURNAL OF VIROLOGY, 2004, 78 (01) : 94 - 103
  • [2] Immunological and virological characteristics of human immunodeficiency virus type 1 superinfection: implications in vaccine design
    Yang Gao
    Wen Tian
    Xiaoxu Han
    Feng Gao
    Frontiers of Medicine, 2017, 11 : 480 - 489
  • [3] Immunological and virological characteristics of human immunodeficiency virus type 1 superinfection: implications in vaccine design
    Gao, Yang
    Tian, Wen
    Han, Xiaoxu
    Gao, Feng
    FRONTIERS OF MEDICINE, 2017, 11 (04) : 480 - 489
  • [4] A novel role for the viral Rev protein in promoting resistance to superinfection by human immunodeficiency virus type 1
    Levin, Aviad
    Hayouka, Zvi
    Friedler, Assaf
    Brack-Werner, Ruth
    Volsky, David J.
    Loyter, Abraham
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 1503 - 1513
  • [5] Human Immunodeficiency Virus Type 1 Superinfection Occurs despite Relatively Robust Neutralizing Antibody Responses
    Blish, Catherine A.
    Dogan, Ozge C.
    Derby, Nina R.
    Nguyen, Minh-An
    Chohan, Bhavna
    Richardson, Barbra A.
    Overbaugh, Julie
    JOURNAL OF VIROLOGY, 2008, 82 (24) : 12094 - 12103
  • [6] CONSEQUENCES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUPERINFECTION OF CHRONICALLY INFECTED-CELLS
    KIM, JH
    MOSCA, JD
    VAHEY, MT
    MCLINDEN, RJ
    BURKE, DS
    REDFIELD, RR
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (09) : 875 - 882
  • [7] REACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 IN MACAQUES AFTER SIMIAN IMMUNODEFICIENCY VIRUS SIVMAC SUPERINFECTION
    PETRY, H
    DITTMER, U
    STAHLHENNIG, C
    COULIBALY, C
    MAKOSCHEY, B
    FUCHS, D
    WACHTER, H
    TOLLE, T
    MORYSWORTMANN, C
    KAUP, FJ
    JURKIEWICZ, E
    LUKE, W
    HUNSMANN, G
    JOURNAL OF VIROLOGY, 1995, 69 (03) : 1564 - 1574
  • [8] LACK OF DETECTABLE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN ANTIBODY-NEGATIVE CHILDREN BORN TO HUMAN IMMUNODEFICIENCY VIRUS-INFECTED MOTHERS
    JONES, DS
    ABRAMS, E
    OU, CY
    NESHEIM, S
    CONNOR, E
    DAVENNY, K
    THOMAS, P
    SAWYER, M
    KRASINSKI, K
    BAMJI, M
    RAPIER, J
    KILBOURNE, B
    ROGERS, M
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (03) : 222 - 227
  • [9] Lack of detection of human immunodeficiency virus type 1 in the saliva of infected children and adolescents
    Melvin, AJ
    Tamura, GS
    House, JK
    Hobson, AC
    Cone, RW
    Frenkel, LM
    Burchett, S
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1997, 151 (03): : 228 - 232
  • [10] Primary human immunodeficiency virus type 1 infection may vary in time, place, and person
    Hudson, CP
    Levett, PN
    CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) : 282 - 283